Lela  Buckingham  to  Antibodies, Monoclonal, Humanized
                            
                            
                                This is a "connection" page, showing publications  Lela  Buckingham  has written about  Antibodies, Monoclonal, Humanized.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.043
         
        
        
     
 
    
        
        - 
            A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation. Oncologist. 2021 10; 26(10):811-817.
            
            
                Score: 0.043